A board member of Dexcom told the SEC about a plan to sell $550K of Dexcom shares around Sep 15, 2026. The shares came from pay, which is the usual reason to sell.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 144 — Notice of Proposed Sale of Securities

All the details

Dates, kept separate

Planned sale date: Sep 15, 2026
Reporting period: Not applicable
Notice filed with the SEC: Sep 15, 2026

DirectorPlanned saleShares from pay

Context

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001959173-26-006959
Filed / recorded: Sep 15, 2026, 1:52 PM UTC

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Added to OQRO

Oct 2, 2026, 11:01 AM UTC

Parser

form144-v1

Data quality

Read from the record; company matched by name

Issuer

DEXCOM INC

Issuer CIK

1093557

Table

Non-derivative (Table I)

Transaction date

—

Shares / units

—

Price per share

—

Shares owned after

—

Ownership form

Direct

Amendment

Around the same time

Officer sold ~$221K of Dexcom

Scheduled in advance7d ago

Officer plans to sell ~$221K of Dexcom

Planned, from pay9d ago

Director sold ~$130K of Dexcom

Scheduled in advance3w ago